Oct 31, 2022 / 05:30AM GMT
Presentation
Oct 31, 2022 / 05:30AM GMT
=====================
Corporate Participants
=====================
* Hiroyuki Okuzawa
Daiichi Sankyo Company, Limited - Senior Executive Officer, Global Head of Corporate Planning & Management Div., CFO and Director
* Sunao Manabe
Daiichi Sankyo Company, Limited - President, Group CEO & Representative Director
* Wataru Takasaki
Daiichi Sankyo Company, Limited - Executive Officer, Head of R&D Division & VP of Precision Medicine Function
=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Naomi Kumagai
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., Research Division - Senior Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
*
Daiichi Sankyo Co Ltd
(STU:D4S)
€
31.43
-1.47 (-4.47%)
Market Cap: 60.27 Bil
Enterprise Value: 53.11 Bil
PE Ratio: 42.98
PB Ratio: 5.83
GF Score: 90/100 Q2 2023 Daiichi Sankyo Co Ltd Earnings Presentation Transcript
Oct 31, 2022 / 05:30AM GMT
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot